STEVENS CAPITAL MANAGEMENT LP

Position in PFE — Pfizer Inc

CIK 1134813 RADNOR, PA

Position in PFE

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,051,447

-$2,886,475 QoQ

Shares Held

85,193

-56.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.58%

of 13F equity value

Holder Rank

#950

of 2,821 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

STEVENS CAPITAL MANAGEMENT LP holds $7,554,742 across 5 Drug Manufacturers - General names. PFE ranks #2 (27.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,749	$3,297,233
2	PFE	Pfizer Inc This page	85,193	$2,051,447
3	GILD	Gilead Sciences, Inc.	6,346	$801,753
4	JNJ	Johnson & Johnson	3,007	$763,687
5	NVO	Novo Nordisk A S	13,363	$640,622

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,051,447	85,193	-56.0%	Shares	Sole	2026-08-11
2025-09-30	$4,937,922	193,796	+136.7%	Shares	Sole	2025-11-10
2025-03-31	$2,074,991	81,886	-17.3%	Shares	Sole	2025-05-07
2024-09-30	$2,866,130	99,037	+136.7%	Shares	Sole	2024-11-14
2024-03-31	$1,161,282	41,848	+92.3%	Shares	Sole	2024-05-08
2023-06-30	$798,230	21,762	-25.0%	Shares	Sole	2023-08-14
2023-03-31	$1,183,730	29,013	+499.9%	Shares	Sole	2023-05-12
2022-12-31	$247,796	4,836	-91.8%	Shares	Sole	2023-02-06
2022-03-31	$3,037,863	58,680	+612.7%	Shares	Sole	2022-05-13
2021-12-31	$486,217	8,234	-49.5%	Shares	Sole	2022-01-28
2021-09-30	$700,847	16,295	-47.1%	Shares	Sole	2021-11-12
2021-06-30	$1,206,793	30,817	-25.1%	Shares	Sole	2021-08-12
2020-09-30	$1,509,689	41,136	-76.9%	Shares	Sole	2020-11-13
2020-06-30	$5,811,973	177,736	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.